Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors.
Frontiers in immunology · 2022 · 291 citations · Ashish Manne
Gastrointestinal Stromal Tumors (GIST): A Population-Based Study Using the SEER Database, including Management and Recent Advances in Targeted Therapy.
Cancers · 2022 · 48 citations · Nabin Karki
Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives.
Cancers · 2022 · 38 citations · Nabin Karki
Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma.
NPJ precision oncology · 2025 · 16 citations · Ashish Manne
The Role of Insulin Resistance in Cancer.
Current oncology (Toronto, Ont.) · 2025 · 12 citations · Shivani Modi
Large Language Models for Adverse Drug Events: A Clinical Perspective.
Journal of clinical medicine · 2025 · 11 citations · Ashish Manne
Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management.
Cancers · 2022 · 25 citations · Nabin Karki
Obesity and Early-Onset Breast Cancer and Specific Molecular Subtype Diagnosis in Black and White Women: NIMHD Social Epigenomics Program.
JAMA network open · 2024 · 18 citations · Pranitha Prodduturvar